SOHM Inc SHMN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SHMN is a good fit for your portfolio.
News
-
SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California
-
SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients’ Brand Chewables
-
SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
-
SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors
-
SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing as VP of Quality with Immediate Effect
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.01
- Market Cap
- $2.54 Mil
- Volume/Avg
- 4.4 Mil / 4.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
SOHM Inc is a pharmaceutical company. It is engaged in developing, manufacturing and distributing generic, branded generic, private label, and company-innovated pharmaceuticals, cosmeceuticals and nutraceutical products. Its product portfolio comprises Analgesics, Antibiotics, Capsules, Tablets, Injections and others. The organization markets and sells its generic drugs globally but focuses primarily on emerging markets in Africa, Latin America, Southeast Asia and the European Union.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.sohm.com
Valuation
|
Metric
|
SHMN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SHMN
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
SHMN
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Prdf | $83.6 Bil | |
MKKGY
| Merck KGaA ADR | Cqyyqx | $77.2 Bil | |
HLN
| Haleon PLC ADR | Mlwdz | $38.8 Bil | |
VTRS
| Viatris Inc | Myfft | $11.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jpv | $11.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Kycg | $11.0 Bil | |
CTLT
| Catalent Inc | Zdstbt | $7.2 Bil | |
PRGO
| Perrigo Co PLC | Yff | $4.2 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jbwvh | $3.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Btzy | $2.8 Bil |